Available in 10 markets
State Street® SPDR® MSCI World Health Care UCITS ETF
State Street® SPDR® MSCI World Health Care UCITS ETF is an exchange-traded fund (ETF) from SPDR, traded under the ticker WHEA (ISIN IE00BYTRRB94). In a single purchase you get a diversified basket of holdings rather than a stake in just one business. At its core it is a focused, thematic fund: it concentrates on the health care part of the…
Opens the screener with this filter applied.
About this fund
What you own
The MSCI World Health Care 35/20 Capped Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 113 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of $100 invested — the line starts at $100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
Return, year by year
How bumpy has it been?
The bigger picture
What's inside
The 10 biggest holdings make up 46.2% of the fund — the rest is spread across roughly 102 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | Eli Lilly and Company | 11.5% |
| 2 | Johnson & Johnson | 7.5% |
| 3 | AbbVie Inc. | 5.3% |
| 4 | UnitedHealth Group Incorporated | 4.3% |
| 5 | Merck & Co. Inc. | 4.0% |
| 7 | Novartis AG | 3.3% |
| 8 | AstraZeneca PLC | 2.8% |
| 9 | Amgen Inc. | 2.7% |
| 10 | Thermo Fisher Scientific Inc. | 2.6% |
| 11 | Abbott Laboratories | 2.3% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| LSE | WHEA | USD | ★ Primary |
| CHF listings | |||
| SIX | WHEA | CHF | |
| EUR listings | |||
| Borsa Italiana | WHEA | EUR | |
| Euronext Amsterdam | WHEA | EUR | |
| Frankfurt | SPFS | EUR | |
| USD listings | |||
| B2 | WHEA | USD | |
| B2 | WHEAEUR | USD | |
| B3 | HEAWL | USD | |
| B3 | WHEAZ | USD | |
| B3 | WHEAM | USD | |
| B3 | WHEAL | USD | |
| B3 | WHEAA | USD | |
| B3 | SPFSD | USD | |
| B4 | WHEAUSD | USD | |
| B4 | WHEAEUR | USD | |
| E1 | WHEAGBX | USD | |
| E1 | WHEAUSD | USD | |
| E1 | WHEAEUR | USD | |
| EB | WHEAZ | USD | |
| EB | HEAWL | USD | |
| EB | WHEAL | USD | |
| EO | WHEAGBX | USD | |
| EO | WHEAUSD | USD | |
| EO | WHEAEUR | USD | |
| EP | WHEAEUR | USD | |
| EP | WHEAUSD | USD | |
| EU | WHEAUSD | USD | |
| EU | WHEAEUR | USD | |
| EU | WHEAGBX | USD | |
| EZ | WHEAEUR | USD | |
| EZ | WHEAUSD | USD | |
| GD | SPFS | USD | |
| GF | SPFS | USD | |
| GH | SPFS | USD | |
| GS | SPFS | USD | |
| GT | SPFS | USD | |
| GZ | SS49 | USD | |
| IX | HEAWL | USD | |
| IX | WHEAL | USD | |
| IX | WHEAZ | USD | |
| L1 | WHEAZ | USD | |
| L1 | WHEAM | USD | |
| L1 | WHEAL | USD | |
| L1 | WHEAA | USD | |
| L1 | SPFSD | USD | |
| L1 | HEAWL | USD | |
| L3 | WHEAA | USD | |
| L3 | WHEAZ | USD | |
| L3 | WHEAM | USD | |
| L3 | WHEAL | USD | |
| L3 | SPFSD | USD | |
| L3 | HEAWL | USD | |
| LA | SPFS | USD | |
| London Stock Exchange | WHEA | USD | |
| LSE | HEAW | USD | |
| LU | SPFS | USD | |
| PO | HEAWL | USD | |
| PO | SPFSD | USD | |
| PO | WHEAA | USD | |
| PO | WHEAL | USD | |
| PO | WHEAM | USD | |
| PO | WHEAZ | USD | |
| PQ | SWOOF | USD | |
| PZ | WHEA | USD | |
| QT | SPFS | USD | |
| QX | WHEAL | USD | |
| QX | WHEAZ | USD | |
| S1 | SPFSD | USD | |
| S1 | WHEAL | USD | |
| S4 | SPFSD | USD | |
| SE | WHEA | USD | |
| T2 | WHEAEUR | USD | |
| T2 | WHEAUSD | USD | |
| TH | SPFS | USD | |
| US | SWOOF | USD | |
| UV | SWOOF | USD | |
| WT | WHEAUSD | USD | |
| WT | WHEAEUR | USD | |
| X2 | WHEAEUR | USD | |
| X2 | WHEAGBX | USD | |
| X2 | WHEAUSD | USD | |
| X9 | WHEAEUR | USD | |
| X9 | WHEAUSD | USD | |
| XA | WHEAUSD | USD | |
| XA | WHEAGBX | USD | |
| XA | WHEAEUR | USD | |
| XE | WHEAEUR | USD | |
| XE | WHEAGBX | USD | |
| XE | WHEAUSD | USD | |
| XF | WHEAEUR | USD | |
| XF | WHEAGBX | USD | |
| XF | WHEAUSD | USD | |
| XG | WHEAUSD | USD | |
| XG | WHEAGBX | USD | |
| XG | WHEAEUR | USD | |
| XH | WHEAEUR | USD | |
| XH | WHEAGBX | USD | |
| XH | WHEAUSD | USD | |
| XJ | WHEAEUR | USD | |
| XJ | WHEAGBX | USD | |
| XJ | WHEAUSD | USD | |
| XL | WHEAUSD | USD | |
| XL | WHEAGBX | USD | |
| XL | WHEAEUR | USD | |
| XO | WHEAEUR | USD | |
| XO | WHEAGBX | USD | |
| XO | WHEAUSD | USD | |
| XQ | WHEAGBX | USD | |
| XT | WHEAEUR | USD | |
| XU | WHEAEUR | USD | |
| XU | WHEAGBX | USD | |
| XU | WHEAUSD | USD | |
| XV | WHEAEUR | USD | |
| XV | WHEAGBX | USD | |
| XV | WHEAUSD | USD | |
| XW | WHEAUSD | USD | |
| XW | WHEAGBX | USD | |
| XW | WHEAEUR | USD | |
| XX | WHEAEUR | USD | |
| XX | WHEAGBX | USD | |
| XX | WHEAUSD | USD | |
| XZ | WHEAGBX | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-08-12 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | Eli Lilly and Company | 11.5% |
| 2 | Johnson & Johnson | 7.5% |
| 3 | AbbVie Inc. | 5.3% |
| 4 | UnitedHealth Group Incorporated | 4.3% |
| 5 | Merck & Co. Inc. | 4.0% |
| 7 | Novartis AG | 3.3% |
| 8 | AstraZeneca PLC | 2.8% |
| 9 | Amgen Inc. | 2.7% |
| 10 | Thermo Fisher Scientific Inc. | 2.6% |
| 11 | Abbott Laboratories | 2.3% |
| 12 | Gilead Sciences Inc. | 2.0% |
| 13 | Pfizer Inc. | 1.8% |
| 14 | Novo Nordisk A/S Class B | 1.8% |
| 15 | Intuitive Surgical Inc. | 1.7% |
| 16 | Bristol-Myers Squibb Company | 1.6% |
| 17 | Vertex Pharmaceuticals Incorporated | 1.6% |
| 18 | Danaher Corporation | 1.5% |
| 19 | CVS Health Corporation | 1.4% |
| 20 | Stryker Corporation | 1.4% |
| 21 | Medtronic Plc | 1.4% |
| 22 | McKesson Corporation | 1.2% |
| 23 | GSK plc | 1.2% |
| 24 | Sanofi SA | 1.1% |
| 25 | Elevance Health Inc. | 1.0% |
| 26 | Regeneron Pharmaceuticals Inc. | 1.0% |
| 27 | Boston Scientific Corporation | 0.9% |
| 28 | Cigna Group | 0.9% |
| 29 | HCA Healthcare Inc | 0.8% |
| 30 | HOYA CORPORATION | 0.7% |
| 31 | Cencora Inc. | 0.7% |
| 32 | EssilorLuxottica SA | 0.7% |
| 33 | Takeda Pharmaceutical Co. Ltd. | 0.7% |
| 34 | Bayer AG | 0.6% |
| 35 | Cardinal Health Inc. | 0.6% |
| 36 | argenx SE | 0.6% |
| 37 | Edwards Lifesciences Corporation | 0.6% |
| 38 | Becton Dickinson and Company | 0.6% |
| 39 | Lonza Group AG | 0.6% |
| 40 | CSL Limited | 0.6% |
| 41 | Humana Inc. | 0.5% |
| 42 | IDEXX Laboratories Inc. | 0.5% |
| 43 | Haleon PLC | 0.5% |
| 44 | Teva Pharmaceutical Industries Limited Sponsored ADR | 0.5% |
| 45 | Natera Inc. | 0.5% |
| 46 | Agilent Technologies Inc. | 0.5% |
| 47 | Galderma Group AG | 0.5% |
| 48 | IQVIA Holdings Inc | 0.5% |
| 49 | Waters Corporation | 0.5% |
| 50 | Sandoz Group Ltd | 0.4% |
| 51 | Veeva Systems Inc. Class A | 0.4% |
| 52 | Alcon AG | 0.4% |
| 53 | DexCom Inc. | 0.4% |
| 54 | GE Healthcare Technologies Inc. | 0.4% |
| 55 | ResMed Inc. | 0.4% |
| 56 | Revolution Medicines Inc. | 0.4% |
| 57 | Otsuka Holdings Co. Ltd. | 0.4% |
| 58 | Centene Corporation | 0.4% |
| 59 | Zoetis Inc. Class A | 0.4% |
| 60 | Chugai Pharmaceutical Co. Ltd. | 0.4% |
| 61 | Biogen Inc. | 0.4% |
| 62 | UCB S.A. | 0.4% |
| 63 | Alnylam Pharmaceuticals Inc | 0.4% |
| 64 | Daiichi Sankyo Company Limited | 0.3% |
| 65 | Illumina Inc. | 0.3% |
| 66 | Mettler-Toledo International Inc. | 0.3% |
| 67 | Labcorp Holdings Inc. | 0.3% |
| 68 | Insmed Incorporated | 0.3% |
| 69 | Quest Diagnostics Incorporated | 0.3% |
| 70 | West Pharmaceutical Services Inc. | 0.3% |
| 71 | Astellas Pharma Inc. | 0.3% |
| 72 | Royalty Pharma Plc Class A | 0.3% |
| 73 | STERIS plc | 0.3% |
| 74 | Fresenius SE & Co. KGaA | 0.3% |
| 75 | Koninklijke Philips N.V. | 0.3% |
| 76 | Terumo Corporation | 0.3% |
| 77 | Merck KGaA | 0.2% |
| 78 | Incyte Corporation | 0.2% |
| 79 | Genmab A/S | 0.2% |
| 80 | United Therapeutics Corporation | 0.2% |
| 81 | Zimmer Biomet Holdings Inc. | 0.2% |
| 82 | Cooper Companies Inc. | 0.2% |
| 83 | Siemens Healthineers AG | 0.2% |
| 84 | Fisher & Paykel Healthcare Corporation Limited | 0.2% |
| 85 | Sonova Holding AG | 0.2% |
| 86 | Neurocrine Biosciences Inc. | 0.2% |
| 87 | Olympus Corp. | 0.2% |
| 88 | Straumann Holding AG | 0.2% |
| 89 | Roche Holding Ltd | 0.2% |
| 90 | Medline Inc. Class A | 0.2% |
| 91 | Shionogi & Co. Ltd. | 0.2% |
| 92 | Smith & Nephew plc | 0.1% |
| 93 | Sigma Healthcare Ltd | 0.1% |
| 94 | Orion Oyj Class B | 0.1% |
| 95 | Insulet Corporation | 0.1% |
| 96 | QIAGEN NV | 0.1% |
| 97 | Fresenius Medical Care AG | 0.1% |
| 98 | Eurofins Scientific SE | 0.1% |
| 99 | Eisai Co. Ltd. | 0.1% |
| 100 | Swedish Orphan Biovitrum AB | 0.1% |
| 101 | Coloplast A/S Class B | 0.1% |
| 102 | Sonic Healthcare Limited | 0.1% |
| 103 | Abivax SA | 0.1% |
| 104 | Pro Medicus Ltd. | 0.1% |
| 105 | Sartorius AG Pref | 0.1% |
| 106 | Recordati S.p.A. | 0.1% |
| 107 | Cochlear Limited | 0.1% |
| 108 | Ipsen SA | 0.1% |
| 109 | Sartorius Stedim Biotech SA | 0.1% |
| 110 | Kyowa Kirin Co. Ltd. | 0.1% |
| 111 | Demant A/S | 0.0% |
| 112 | Financiere de Tubize S.A. | 0.0% |
| 113 | bioMerieux SA | 0.0% |
How it ranks vs peers
Versus the Equity (stocks) · Global · Health Care · USD ETFs we track.
Advanced risk
Concentration depth
Roughly 113 companies are held, but the largest names carry most of the weight — so it behaves like ~29 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| State Street® SPDR® MSCI World Health Care UCITS ETFSPDRYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysical Tracks a different index in the same category. | StocksPhysical Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksAccumulatingPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. |
| Index tracked | MSCI World Health Care 35/20 Capped Index | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.30% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.30% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.00% |
| Fund size | €588.5M | €166B | €146.5B | €128.1B | €127.6B | €35.6B | €30.7B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +7.4% | +16.8% | +17.8% | +18.3% | +17.8% | ||
| 5-yr return p.a. | +4.7% | +9.7% | +9.3% | +11.3% | +7.1% | ||
| # holdings | 113 | 1,356 | 1,356 | 1,356 | 1,356 | 2,459 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.